We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QEP
801
DELISTED
QEP RESOURCES, INC.
QEP
-5,747,744
Closed -$13.7M
ACIA
802
DELISTED
Acacia Communications Inc
ACIA
-180,151
Closed -$13.1M
EV
803
DELISTED
Eaton Vance Corp.
EV
-150,037
Closed -$10.2M
CBMG
804
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
-235,317
Closed -$4.33M
EIGI
805
DELISTED
Endurance International Group Holdings, Inc.
EIGI
-987,610
Closed -$9.33M
OSB
806
DELISTED
Norbord Inc.
OSB
-386,005
Closed -$16.7M
FBM
807
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
-232,523
Closed -$4.47M
EIDX
808
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
-67,551
Closed -$8.89M
CXO
809
DELISTED
CONCHO RESOURCES INC.
CXO
-115,782
Closed -$6.76M
TIF
810
DELISTED
Tiffany & Co.
TIF
-211,070
Closed -$27.7M
BMY.RT
811
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-194,693
Closed -$134K
RESI
812
DELISTED
Front Yard Residential Corporation Common Stock
RESI
-621,829
Closed -$10.1M

Similar funds

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.